{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2019, Part 2

Activity Steps

1 Activity
2 Take Test 3Certificate

Purpose of Activity

To provide an overview of eight drugs recently approved by the FDA.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Discuss the indications for the eight newly approved drugs.
  2. Identify nursing considerations for these new drugs.

Disclosures

The author and planners have disclosed no potential conflicts of interest, financial or otherwise.

Price: $17.95

Credits:

  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • KY-BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Planner
Test Code: N0519B
Published: May 2019
Expires: 12/31/2026
Sources: Nursing2020
Required Passing Score: 13/18 (72%)
Authors: Daniel A. Hussar, PhD
Categories: Advanced Pharmacology Hours , Advanced Practice Nursing , Drug Therapy , Pharmacology
Specialties: HIV or AIDS Care, Women's Health
Topics: Endometriosis , HIV/AIDS , Hyperkalemia , Opioids , Psoriasis , Rheumatoid Arthritis , Shock